A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab
Crossref DOI link: https://doi.org/10.1007/s40262-017-0546-0
Published Online: 2017-05-18
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosario, Maria
Dirks, Nathanael L.
Milch, Catherine
Parikh, Asit
Bargfrede, Michael
Wyant, Tim
Fedyk, Eric
Fox, Irving
Funding for this research was provided by:
Takeda Pharmaceuticals Company Limited
License valid from 2017-05-18